Tetramisole Hydrochloride
Specifications
5086-74-8CAS Number
225-799-5EC Number
6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazole;hydrochlorideIUPAC Name
C11H13ClN2SChemical Formula
240.75 g/molMolecular Weight
Tetramisole hydrochloride; 5086-74-8; Tetramisole HCl; Anthelvet; Concurat; Citarin; Ascarotrat; Nilverom; Ripercol; Pig Wormer; Orovermol; Spartakon; Solaskil hydrochloride; McN-JR-8299-11; Citarin (VAN); McN JR 8299; Bayer 9051; Tetramisole hydrochloride [USAN]; R 8299; McN-JR-8299; NSC 170985; UNII-0NDK265MCV; EINECS 225-799-5; 0NDK265MCV; NSC-170985; Tetramisole hydrochloride, dl-; Levamisole dl-form hydrochloride; Tetramisole hydrochloride (USAN); DTXSID101017245; DL-6-Phenyl-2,3,5,6-tetrahydroimidazole(2,1-b)thiazole-hydrochloride; (+-)-2,3,5,6-Tetrahydro-6-phenylimidazo(2,1-b)thiazole monohydrochloride; TETRAMISOLE HYDROCHLORIDE [MART.]; TETRAMISOLE HYDROCHLORIDE [WHO-DD]; LEVAMISOLE DL-FORM HYDROCHLORIDE [MI]; Imidazo(2,1-b)thiazole, 2,3,5,6-tetrahydro-6-phenyl-, monohydrochloride, (+-)-; Imidazo[2,1-b]thiazole, 2,3,5,6-tetrahydro-6-phenyl-, monohydrochloride; TETRAMISOLE HYDROCHLORIDE (MART.); Imidazo(2,1-b)thiazole, 2,3,5,6-tetrahydro-6-phenyl-, monohydrochloride; RefChem:188800; (+-)-Tetramisole hydrochloride; DTXCID301475435; 225-799-5; Nilverm; Tetramisole (hydrochloride); 6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole hydrochloride; MFCD00005536; 6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazole hydrochloride; Ashitetra; Duxamintic; 4641-34-3; 6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazole;hydrochloride; mcn-jr 8299; SR-01000076148; DL-Tetramisole hydrochloride; Ripereol; (+/-)-Tetramisole hydrochloride;DL-Tetramisole hydrochloride;R-829; (6S)-6-phenyl-2H,3H-2-imidazolino[2,1-b]1,3-thiazolidine, chloride; (+/-)-Tetramisole Hydrochloride; NCGC00094446-03; Prestwick_854; Tetramisol hydrochloride; (.+-.)-Anthelvet; dl tetramisole hydrochloride; McNJR8299; SCHEMBL44230; BMK1-H7; Imidazo[2, 2,3,5,6-tetrahydro-6-phenyl-, monohydrochloride; MLS000028416; orb320484; orb363753; CHEBI:9496; CHEMBL554891; orb3140169; MSK5595; (.+-.)-Tetramisole hydrochloride; GLXC-07814; HMS1569N11; Pharmakon1600-01503245; Pharmakon1600-01505679; HY-B1194; Tox21_501194; MSK5595-100M; NSC170985; NSC215179; NSC758437; NSC759175; s1939; s4094; SBB056947; AKOS015900432; CCG-213508; CCG-220545; CCG-222498; CS-4801; HS-0026; LP01194; NSC-215179; NSC-758437; NSC-759175; SB18744; NCGC00094446-01; NCGC00094446-02; NCGC00094446-04; NCGC00094446-05; NCGC00261879-01; AC-22590; DA-78357; RP 16535; SMR000058395; SY066619; DB-043639; EU-0101194; NS00081425; ST50989904; WLN: T55 AN DN FS DUTJ CR &GH -R; D06091; D70698; EN300-296086; T 1512; Tetramisole hydrochloride, phosphatase inhibitor; F433645; Levamisole hydrochloride [for biochemical Research]; SR-01000076148-1; SR-01000076148-5; Q27108410; Tetramisole hydrochloride Solution in Methanol, 100ug/mL; 2,5,6-Tetrahydro-6-phenylimidazo[2,1-b]thiazole hydrochloride; Tetramisole hydrochloride, VETRANAL(TM), analytical standard; ()-Tetramisole hydrochloride;DL-Tetramisole hydrochloride;R-829; 6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole;hydrochloride; 6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazolehydrochloride; 6-phenyl-2H,3H,5H,6H-imidazo[2,1-b][1,3]thiazole hydrochloride; DL-6-Phenyl-2,5,6-tetrahydroimidazole[2,1-b]thiazole-hydrochloride; (.+-.)-2,5,6-Tetrahydro-6-phenylimidazo[2,1-b]thiazole monohydrochloride; Imidazo[2, 2,3,5,6-tetrahydro-6-phenyl-, monohydrochloride, (.+-.)-; ( inverted question mark)-2,3,5,6-Tetrahydro-6-phenylimidazo[2,1-b]thiazole hydrochloride; (+/-)-2,3,5,6-TETRAHYDRO-6-PHENYLIMIDAZO(2,1-B)THIAZOLE MONOHYDROCHLORIDE; 6-Phenyl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazole--hydrogen chloride (1/1); IMIDAZO(2,1-B)THIAZOLE, 2,3,5,6-TETRAHYDRO-6-PHENYL-, MONOHYDROCHLORIDE, (+/-)-; Imidazo(2,1-b)thiazole,2,3,5,6-tetrahydro-6-phenyl-, monohydrochloride, (-)- (8CI); Imidazo[2,1-b]thiazole, 2,3,5,6-tetrahydro-6-phenyl-, hydrochloride (1:1)Synonyms
